![]() Some info that the I have found about a SPAC is as follows: QUESTION: Where are we toward the completion of this process? 50% / 75% / 90% ? The Company is pursuing the fastest path to trading first and will proceed down the list as it moves towards its ultimate goal of bringing all the GBXI conglomerate company shares back trading again. The Company has several options on the list for trading resumption as it pursues its regulatory approvals. ![]() Then On you posted the following: "GBXI Corporate Filings, Financials, and trading status has been delayed due to change of control filings and approvals. On it was announced that GBXI signs the first 3 acquisitions for the GBXI Conglomerate (follow link below for details) #7 is the US Patent that was awarded to CBIS which describes the formulation used to treat certain neurological ailments such as ODD, ADD, etc. #1-6 Represents the drug formulations developed by DFCI during the 5yr RCA for treatment of the following cancers: THE RESULTS ARE NOW KNOWN:įor the $1.8mil investment with DFCI, several Cancer Killing Formulations have been developed. ![]() NOW, On the Expanded RCA with DFCI has ended. $1.8M) to develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers. Then on 1st Frontiers In Oncology Article: "Nano Particle Drone to Target Lung Cancer with Radio Sensitizers & Cannabis." - KILLING CANCERĪnd then again on CBIS expanded the RCA with DFCI for 5 yrs. Research Collaboration Agreement (RCA) with Dana Farber Cancer Institute (DFCI) to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers. Bob was still at CBIS) and I made my last purchase in June 2017 just prior to the Hemp Seizure that F'k-up everything for CBIS going forward.īUT, on CBIS Entered into 1 yr. I made my first CBIS purchase in Sept 2014 (Dr. All rights reserved.As a long-standing Loyal Shareholder, I hope that this posting finds you in good health and good spirits. © currentYear E*TRADE from Morgan Stanley. Statement of Financial Condition | About Asset Protection | Account Agreements and Disclosures | Quarterly 606 Report | Business Resiliency Plan System response and account access times may vary due to a variety of factors, including trading volumes, market conditions, system performance, and other factors. E*TRADE from Morgan Stanley and Morgan Stanley at Work are registered trademarks of Morgan Stanley. All entities are separate but affiliated subsidiaries of Morgan Stanley. Banking products and services provided by Morgan Stanley Private Bank, National Association, Member FDIC. Commodity futures and options on futures products and services offered by E*TRADE Futures LLC, Member NFA Stock plan administration solutions and services offered by E*TRADE Financial Corporate Services, Inc., and are a part of Morgan Stanley at Work. Securities products and investment advisory services offered by Morgan Stanley Smith Barney LLC, Member SIPC and a Registered Investment Adviser. Top five lists are not a recommendation by E*TRADE Securities or its affiliates to buy, sell or hold any security, financial product or instrument, nor is it an endorsement of any specific security, company, fund family, product, or service. Consequently, brokerage commissions will reduce the performance. ETF shares cannot be redeemed directly from the ETF. For quarterly and current performance metrics, please click on the fund name. Current performance may be lower or higher than the performance data quoted. Your investment may be worth more or less than your original cost at redemption. ![]() Past performance is not an indication of future results and investment returns and share prices will fluctuate on a daily basis. Top five lists are not a recommendation by Morgan Stanley Smith Barney LLC or its affiliates to buy, sell or hold any security, financial product or instrument, nor is it an endorsement of any specific security, company, fund family, product, or service.Įxchange-traded funds (ETFs) on the list were identified by the following criteria: ETFs available on the E*TRADE platform with the highest 1-year total return and overall Morningstar rating of 4 or 5 stars, excluding exchange-traded notes, sector ETFs, and leveraged ETFs.ĭata quoted represents past performance.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |